Nanobiotix S.A. (0QAV.L)

EUR 3.48

(1.75%)

Gross Profit Summary of Nanobiotix S.A.

Nanobiotix S.A.'s latest annual gross profit in 2023 was 42.35 Million EUR , up 1192.98% from previous year.
Nanobiotix S.A.'s latest quarterly gross profit in 2024 Q2 was 9.28 Million EUR , down 0.0% from previous quarter.
Nanobiotix S.A. reported a annual gross profit of 3.27 Million EUR in annual gross profit 2022, up 23.76% from previous year.
Nanobiotix S.A. reported a annual gross profit of 2.64 Million EUR in annual gross profit 2021, up 13.85% from previous year.
Nanobiotix S.A. reported a quarterly gross profit of 2.55 Million EUR for 2023 Q2, down 0.0% from previous quarter.
Nanobiotix S.A. reported a quarterly gross profit of 35.77 Million EUR for 2023 Q4, down 0.0% from previous quarter.

Annual Gross Profit Chart of Nanobiotix S.A. (2023 - 2012)

Historical Annual Gross Profit of Nanobiotix S.A. (2023 - 2012)

Year	Gross Profit	Gross Profit Growth
2023	42.35 Million EUR	1192.98%
2022	3.27 Million EUR	23.76%
2021	2.64 Million EUR	13.85%
2020	2.32 Million EUR	-8.5%
2019	2.54 Million EUR	-26.96%
2018	3.47 Million EUR	3815.97%
2017	-93.62 Thousand EUR	-108.35%
2016	1.12 Million EUR	1292.54%
2015	-94.06 Thousand EUR	-103.39%
2014	2.77 Million EUR	73.67%
2013	1.59 Million EUR	64.38%
2012	970.6 Thousand EUR	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q2	9.28 Million EUR	0.0%
2023 Q2	2.55 Million EUR	0.0%
2023 Q4	35.77 Million EUR	0.0%
2023 FY	36.2 Million EUR	1005.25%
2022 Q4	2.69 Million EUR	0.0%
2022 FY	3.27 Million EUR	23.76%
2022 Q2	583 Thousand EUR	0.0%
2021 Q4	569 Thousand EUR	0.0%
2021 Q2	1.31 Million EUR	0.0%
2021 FY	2.64 Million EUR	13.85%
2020 FY	2.32 Million EUR	-8.5%
2020 Q2	1.44 Million EUR	0.0%
2020 Q4	877 Thousand EUR	0.0%
2019 Q4	718 Thousand EUR	0.0%
2019 Q2	1.82 Million EUR	0.0%
2019 FY	2.54 Million EUR	-26.96%
2018 FY	3.47 Million EUR	3815.97%
2018 Q4	1.41 Million EUR	0.0%
2018 Q2	2.06 Million EUR	0.0%
2017 Q2	1.88 Million EUR	0.0%
2017 FY	-93.62 Thousand EUR	-108.35%
2017 Q4	1.83 Million EUR	0.0%
2016 Q2	3.03 Million EUR	0.0%
2016 FY	1.12 Million EUR	1292.54%
2016 Q4	2.38 Million EUR	0.0%
2015 FY	-94.06 Thousand EUR	-103.39%
2015 Q4	2.35 Million EUR	0.0%
2015 Q2	1.65 Million EUR	0.0%
2014 FY	2.77 Million EUR	73.67%
2014 Q2	997.39 Thousand EUR	0.0%
2014 Q4	1.77 Million EUR	0.0%
2013 Q4	929.01 Thousand EUR	0.0%
2013 Q2	666.45 Thousand EUR	0.0%
2013 FY	1.59 Million EUR	64.38%
2012 Q3	252.24 Thousand EUR	0.0%
2012 FY	970.6 Thousand EUR	0.0%
2012 Q4	252.24 Thousand EUR	0.0%

Peer Gross Profit Comparison of Nanobiotix S.A.

Name	Gross Profit	Gross Profit Difference
Boiron SA	358.08 Million EUR	88.171%
Laboratorios Farmaceuticos Rovi, S.A.	483.34 Million EUR	91.236%
Vetoquinol SA	291.37 Million EUR	85.463%
Valneva SE	52.83 Million EUR	19.833%
AB Science S.A.	587 Thousand EUR	-7116.014%
PHAXIAM Therapeutics S.A.	1.32 Million EUR	-3094.419%
Vivoryon Therapeutics N.V.	-3.09 Million EUR	1468.595%
BioSenic S.A.	543 Thousand EUR	-7700.737%
ABIVAX Société Anonyme	3.91 Million EUR	-982.218%
Formycon AG	23.3 Million EUR	-81.755%